학술논문
Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final overall survival analysis
Document Type
Article
Author
Source
In Annals of Oncology March 2022 33(3):321-329
Subject
Language
ISSN
0923-7534